Transplant / Immunocompromised Host Track

Fellows will spend one year in clinical training which includes three months on the Transplant ID service followed by three years of advanced training in the care of transplant / immunocompromised hosts (ICH) and innovative methods of scientific research in this population. Trainees on this track will spend 6 months on the Transplant ID clinical service during their second year and the remaining 2.5 years performing clinical or basic science research focused on transplant/ICH in one of four key areas: 1) laboratory medicine, 2) microbial epidemiology & pathogenesis, 3) host susceptibility & response to infection, or 4) medical management & treatment outcomes.

The research expertise and resources available to Transplant ID trainees at Duke are considerable. Twenty-two faculty with primary appointments in six departments participate in the training program. 

The goal of the Transplant/ICH track is to train physician-scientists to assume leadership and investigate roles related to infectious diseases in the ICH.

Clinical and Basic Science Research Opportunities and Mentors for each category:

Laboratory medicine

  • L. Barth Reller, MD, DTM&H
  • Barbara D. Alexander, MD, MHS

Microbial Epidemiology and Pathogenesis

  • Bryan R. Cullen, PhD
  • Micah Luftig, PhD
  • Joseph Heitman, MD, PhD
  • John R. Perfect, MD
  • J. Andrew Alspaugh, MD
  • Fred S. Dietrich, PhD
  • Daniel J. Sexton, MD
  • Deverick J. Anderson, MD, MPH

Host Susceptibility and Response to Infection

  • Geoffrey S. Ginsburg, MD, PhD
  • Aimee K. Zaas, MD, MHS.
  • David B. Goldstein, PhD
  • Barton F. Haynes, MD
  • Kent J. Weinhold, PhD
  • Georgia D. Tomaras, PhD
  • M. Anthony Moody, MD

Medical Management & Treatment Outcomes

  • G. Ralph Corey, MD
  • Scott M. Palmer, MD, MHS
  • Cameron R. Wolfe, MBBS​